Dal Alert!

Receive alerts from Dalhousie by text message.

X

Dr Ricardo Rendon

Professor

urology-RENDON
Department of Urology

Email: rrendon@dal.ca
Phone: 902-425-3940
Fax: 902-422-0033
Mailing Address: 
VG Site -5th Floor Centennial
Room 5015, 1276 South Park St
Halifax, NS, B3H 2Y9
 
Research & Clinical Interests:
  • Urologic cancer
  • Urologic surgery
  • Minimally invasive surgery
  • Surgery techniques
  • Kidney cancer

 

Education

  • MD (Universidad Javeriana, Bogota, Colombia)
  • Internship (Universidad Javeriana, Bogota, Colombia)
  • Residency (Universidad Javeriana, Bogota, Colombia)
  • Research and Clinical Fellowship (Princess Margaret Hospital and University of Toronto)
  • MSc, Community Health & Epidemiology (Dalhousie University)

Designations

  • FRCSC
  • Director of Clinical Trials (Department of Urology, Dalhousie University)
  • Chair, Research Committee (Department of Urology, Dalhousie University)

Biography

Dr Ricardo A. Rendon is a native of Colombia.  He completed medical school training in 1993 at the Universidad Javeriana in Bogota, Colombia. Subsequently, he completed a rotating internship and Urology residency at Universidad Javeriana in Bogota. Dr Rendon arrived in Canada to complete a two year Research and Clinical Fellowship in Urologic Oncology at the Princess Margaret Hospital and University of Toronto. He obtained a MSc in Community Health and Clinical Epidemiology at Dalhousie University. Dr Rendon obtained his Fellowship of the Royal College of Physicians and Surgeons of Canada in 2007.  He is the Director of the Department of Urology Clinical Trials Unit and the Chair of the Department of Urology Research Committee. Dr. Rendon’s current research interests include kidney cancer and urothelial cell carcinoma, as well as other urologic malignancies.

Selected Publications


Erratum to "The natural history of renal function after surgical management of renal cell carcinoma: Results from the Canadian Kidney Cancer Information System" [Urol Oncol 34(11) (2016) 486.e1-486.e7]., Mason R, Kapoor A, Liu Z, Saarela O, Tanguay S, Jewett M, Finelli A, Lacombe L, Kawakami J, Moore R, Morash C, Black P, Rendon RA. Urol Oncol. 2017 Mar;35(3):124. doi: 10.1016/j.urolonc.2017.01.018.


Disease progression and kidney function after partial vs. radical nephrectomy for T1 renal cancer. Forbes CM, Rendon RA, Finelli A, Kapoor A, Moore RB, Breau RH, Lacombe L, Kawakami J, Drachenberg DE, Pautler SE, Jewett MM, Saarela O, Liu Z, Tanguay S, Black PC. Urol Oncol. 2016 Nov;34(11):486.e17-486.e23. doi: 10.1016/j.urolonc.2016.05.034. Epub 2016 Jul 14.


The natural history of renal function after surgical management of renal cell carcinoma: Results from the Canadian Kidney Cancer Information System. Mason R, Kapoor A, Liu Z, Saarela O, Tanguay S, Jewett M, Finelli A, Lacombe L, Kawakami J, Moore R, Morash C, Black P, Rendon RA. Urol Oncol. 2016 Nov;34(11):486.e1-486.e7. doi: 10.1016/j.urolonc.2016.05.025. Epub 2016 Jun 22.


Surgical management of stage T1 renal tumours at Canadian academic centres. Lavallée LT, Tanguay S, Jewett MA, Wood L, Kapoor A, Rendon RA, Moore RB, Lacombe L, Kawakami J, Pautler SE, Drachenberg DE, Black PC, Lattouf JB, Morash C, Cagiannos I, Liu Z, Breau RH. Can Urol Assoc J. 2015 Mar-Apr;9(3-4):99-106. doi: 10.5489/cuaj.2598. Erratum in: Can Urol Assoc J. 2016 Aug;10 (7-8):E281.


A rare case of bladder chondroma.Carter MD, Rendon RA, Merrimen J. Can Urol Assoc J. 2015 Mar-Apr;9(3-4):E136-8. doi: 10.5489/cuaj.2552..